Glox Therapeutics

Healthcare & Life Sciences

Recent Finacing

Non-dilutive financing

Recent Raise

$1.3M

Glox Therapeutics develops precision antibiotics targeting drug-resistant bacteria, with a focus on creating high-potency bacteriocins to selectively target and kill antibiotic-resistant Gram-negative pathogens while preserving the patient's microbiome.